| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MAHON PAUL A | EVP & GENERAL COUNSEL | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 19 Feb 2026 | 0001231589 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $1,212,049 | +8,300 | +23% | $146.03 | 45,081 | 19 Feb 2026 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | $290,357 | -616 | -1.4% | $471.36 | 44,465 | 19 Feb 2026 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $366,391 | -775 | -1.7% | $472.76 | 43,690 | 19 Feb 2026 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $136,289 | -288 | -0.66% | $473.23 | 43,402 | 19 Feb 2026 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $503,123 | -1,059 | -2.4% | $475.09 | 42,343 | 19 Feb 2026 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $419,255 | -881 | -2.1% | $475.89 | 41,462 | 19 Feb 2026 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $531,485 | -1,114 | -2.7% | $477.10 | 40,348 | 19 Feb 2026 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $1,004,115 | -2,100 | -5.2% | $478.15 | 38,248 | 19 Feb 2026 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | $702,573 | -1,467 | -3.8% | $478.92 | 36,781 | 19 Feb 2026 | Direct | F1, F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | $0 | -8,300 | -17% | $0.000000 | 41,800 | 19 Feb 2026 | Common Stock | 8,300 | $146.03 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| F2 | This transaction was executed in multiple trades at prices ranging from $471.00 to $471.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $472.00 to $472.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $473.02 to $473.785. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $474.50 to $475.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $475.56 to $476.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $476.56 to $477.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $477.58 to $478.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $478.58 to $479.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |